Journal of Clinical Oncology (JCO) Podcast

The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ

Episodes

Total: 418

Moving Forward With Venetoclax-Based Combinations in Younger Adults With Acute Myeloid Leukemia
2021/6/20

Venetoclax in combination with FLAG-IDA chemotherapy shows safety and promising efficacy in both unt

A Deep Dive Into HLA Typing For Unrelated Donor Hematopoietic Cell Transplantation
2021/5/20

This podcast comments on a large registry study evaluating the effect of ultra-high-resolution HLA t

PENELOPE-B: Exploration of CDK4/6 Inhibition in the Adjuvant Setting
2021/5/10

The PENELOPE-B phase III trial did not show a benefit to the addition of one year of the CDK4/6 inhi

ctDNA in DLBCL: A Blueprint for Better Clinical Trials?
2021/4/10

Current clinical characteristics and demographics are not sufficient to capture aggressive disease i

How Can We Expand Eligibility Criteria for Diffuse Large B-Cell Lymphoma Clinical Trials to Serve More Patients?
2021/3/10

This podcast considers the impact of exclusion criteria on clinical trials, generalizability, and th

The Pathologist, the Surgeon, and the Rare Phyllodes Tumor
2020/12/20

This multi-institutional study highlights the heterogeneity of Phyllodes tumors of the breast and th

Cancer Surgery in COVID-19-Free Facilities
2020/9/29

In this study of cancer operations conducted during the COVID-19 pandemic, rates of pulmonary compli

Finding a Needle in a Haystack of Mutations: Using Whole Genome Sequencing to Identify Patients with Low-Risk Myeloma
2020/7/20

This podcast reviews the results of the whole genome sequencing study by Samur and colleagues that i

Advancing Knowledge on the Use of Dexrazoxane in Children With Acute Myeloid Leukemia and Other Childhood Cancers
2020/6/11

This podcast describes a study addressing the use of dexrazoxane as a cardioprotectant in a cohort o

Better Diet – Fewer Side Effects?
2020/4/30

This podcast reviews the results of the observational study by Ladas and colleagues that found prote

Genetic Testing in Breast Cancer Patients: Striking the Balance Between Over Versus Undertesting
2020/3/11

This podcast summarizes and provides commentary on the recent article by Yadav et al. in which the a

High Reward, High Toxicity: Combination Pembrolizumab and Lenvatinib in Advanced Endometrial Cancer
2020/3/1

The combination of pembrolizumab and lenvatinib is a promising second line option for metastatic or

Optimizing Treatment Strategies for Germline BRCA/PALB2 Mutant Pancreatic Adenocarcinoma
2020/1/21

This podcast will discuss the findings from a phase II trial of gemcitabine, cisplatin and PARP inhi

Immune Checkpoint Inhibitor Use in Patients With Inflammatory Bowel Disease: A Closer Look
2020/1/8

Towards improved characterization of immune-related adverse events in the setting of pre-existing au

The High Prevalence of Exercise Intolerance in Adult Survivors of Childhood Cancer Is Predictive of All-Cause Mortality
2020/1/8

This podcast describes a study examining aerobic capacity in a cohort of over 1200 adult survivors o

Leptomeningeal Disease in EGFR-Mutated Lung Cancer: Can We Finally Define a Standard Treatment?
2020/1/8

This podcast describes the results of the BLOOM study, evaluating the efficacy of osimertinib in EGF

Advancing Treatment Options for Mismatch Repair-Deficient Metastatic Colorectal Cancers
2020/1/8

This podcast reviews the results of KEYNOTE 164 investigating the use of pembrolizumab for mismatch

Keeping Mycosis Fungoides in Check: A Study of Pembrolizumab for Relapsed/Refractory MF and Sezary Syndrome
2020/1/6

This podcast evaluates results from a phase II clinical trial of pembrolizumab for relapsed Mycosis

What’s in a Name? An Introductory Guide
2019/12/26

This podcast discusses the results and implications of a recent study on gender bias in speaker intr

Resuming Life After Cancer Therapy: Treatment-Free Survival
2019/12/10

Treatment-free survival is a novel endpoint in immunotherapy. TRANSCRIPT This JCO Podcast provides o